Difficulty: Medium
Average Score: 72%
Practice
In vomiting with pregnancy, it is safe to use:
Correct answer
B
Rationale
In the context of pregnancy, it is crucial to consider the safety of medications due to potential risks to the developing fetus. In the case of vomiting during pregnancy, the safest option is typically Meclezine + Pyridoxine (Option B).
Meclezine is an antihistamine that is commonly used to treat nausea and vomiting, and Pyridoxine (vitamin B6) is also known to be safe during pregnancy and can help alleviate nausea. This combination provides relief without posing significant risks to the fetus, making it a suitable choice for pregnant individuals experiencing vomiting.
Hyoscine (Option A) is not recommended during pregnancy as it can cross the placenta and potentially affect the fetus. Ondansetron (Option C) has been associated with some safety concerns in pregnancy, particularly in the first trimester, although more recent studies have shown conflicting results. Diazepam (Option D) is a benzodiazepine and is generally not recommended during pregnancy due to potential risks of birth defects and other adverse effects on the fetus.
Educationally, it is important for healthcare providers to be aware of safe treatment options for common conditions during pregnancy. Understanding the rationale behind choosing certain medications over others can help ensure the well-being of both the pregnant individual and the developing fetus. By selecting the most appropriate and safe option, healthcare providers can effectively manage symptoms while minimizing potential risks.
Meclezine is an antihistamine that is commonly used to treat nausea and vomiting, and Pyridoxine (vitamin B6) is also known to be safe during pregnancy and can help alleviate nausea. This combination provides relief without posing significant risks to the fetus, making it a suitable choice for pregnant individuals experiencing vomiting.
Hyoscine (Option A) is not recommended during pregnancy as it can cross the placenta and potentially affect the fetus. Ondansetron (Option C) has been associated with some safety concerns in pregnancy, particularly in the first trimester, although more recent studies have shown conflicting results. Diazepam (Option D) is a benzodiazepine and is generally not recommended during pregnancy due to potential risks of birth defects and other adverse effects on the fetus.
Educationally, it is important for healthcare providers to be aware of safe treatment options for common conditions during pregnancy. Understanding the rationale behind choosing certain medications over others can help ensure the well-being of both the pregnant individual and the developing fetus. By selecting the most appropriate and safe option, healthcare providers can effectively manage symptoms while minimizing potential risks.